Related Experiment Videos
Elevated platelet phosphatidylinositol bisphosphate in mediated schizophrenics
I Das1, M A Essali, J de Belleroche
1Department of Psychiatry and Biochemistry, Charing Cross and Westminster Medical School, London, UK.
Schizophrenia Research
|June 1, 1994
Summary
Schizophrenia patients show higher levels of phosphatidyl inositol 4,5-bisphosphate (PIP2) in platelets. This suggests potential signal transduction pathway impairments in schizophrenia, impacting cell signaling.
Area of Science:
- Biochemistry
- Neuroscience
- Cell Biology
Background:
- Phosphatidyl inositol 4,5-bisphosphate (PIP2) is crucial for cellular signaling.
- Abnormalities in PIP2 metabolism are implicated in various neurological disorders.
Purpose of the Study:
- To investigate PIP2 levels in platelets of individuals with schizophrenia.
- To examine PIP2 hydrolysis in response to agonists in schizophrenic patients.
Main Methods:
- Immunoassay was used to quantify PIP2 levels in platelets.
- Platelets were obtained from both schizophrenic patients and healthy controls.
Main Results:
- Resting platelets from schizophrenic patients exhibited significantly elevated PIP2 levels compared to controls.
- Agonist-stimulated PIP2 hydrolysis was also significantly greater in the schizophrenic group.
Conclusions:
- Elevated PIP2 levels and increased hydrolysis in schizophrenia platelets suggest a potential defect in the inositol phospholipid pathway.
- This abnormality may contribute to impaired signal transduction in schizophrenia.